Abstract: Active agent combinations are provided for the treatment and/or prevention of COVID-19.
| # | Name | Date |
|---|---|---|
| 1 | 202347025930.pdf | 2023-04-06 |
| 2 | 202347025930-STATEMENT OF UNDERTAKING (FORM 3) [06-04-2023(online)].pdf | 2023-04-06 |
| 3 | 202347025930-PRIORITY DOCUMENTS [06-04-2023(online)].pdf | 2023-04-06 |
| 4 | 202347025930-FORM 1 [06-04-2023(online)].pdf | 2023-04-06 |
| 5 | 202347025930-DECLARATION OF INVENTORSHIP (FORM 5) [06-04-2023(online)].pdf | 2023-04-06 |
| 6 | 202347025930-COMPLETE SPECIFICATION [06-04-2023(online)].pdf | 2023-04-06 |
| 7 | 202347025930-FORM-26 [12-04-2023(online)].pdf | 2023-04-12 |
| 8 | 202347025930-FORM-26 [13-04-2023(online)].pdf | 2023-04-13 |